The classic ketogenic diet (CKD) as a potential epilepsy treatment with high-fat has not good tolerability in some patients, and so many families refuse to use this diet for long term especially in children younger than 2 year. In the present study, the efficacy and tolerability of the CKD only diet were compared with CKD combined a formulabased powder in children between 1 and 3 yr with intractable epilepsy.
Introduction
Epilepsy is the most common neurologic disorder in children and 20%-25% of these patients are resistant to medical treatments which impose high expenses on the family and affects their quality of life (1, 2) . Other treatment options such as surgery need to have a special epileptic focus. In addition, most of the refractory seizures have genetic origins without any brain epileptic focus, and the surgery option is available only in a small number of countries (1) (2) (3) (4) .
Ketogenic diet has been a well-known treatment for refractory seizures since 1972 with positive effects on patients' social and cognitive abilities (3, (5) (6) (7) . However, most of the studies about ketogenic diet have been designed for children over three years old or in a wide age range group without age categorization (8) (9) (10) (11) (12) . Ketogenic formula powder is a commercial product that tastes similar to infantile formula. In the first days of starting ketogenic diet during which a child often refuses solid food, this formula is simply acceptable and is a suitable alternative (9) . However, there are few studies about the efficacy of the respective diet in children especially children younger than 2 yr old. Therefore, we aimed to study and compare the tolerability and efficacy of classic ketogenic diet with the powder formula in children between 1 and 3 yr of age with intractable epilepsy.
Materials & Methods
Overall, 45 children, 12- were not statistically significant.
The mean±standard deviation of the follow-up duration was 0.671.8 months in CKD only group and 3.08±2.69 months in KetoCal® group. The follow-up duration difference between the two groups was significant (P<0.05).
The frequency of weekly seizures was assessed in 1 st , 3 rd , and 6 th month after intervention in both groups ( Table 1) . About 50% seizure reduction was more prominent in KetoCal® group than CKD only group, and the difference between the two groups was statistically significant (P<0.05).
Seizure reduction between two groups was also compared based on the seizure type. In the KetoCal® group, the therapeutic response in the 3 rd and 6 th months of follow-up was quite remarkable in myoclonic seizures and infantile spasm, with a significant statistical difference (P<0.01) ( Table   2 ). The effect of age, gender, and type of seizure on the therapeutic response were studied. Based on the results ( excluded because of the lack of ketone production.
However this was not seen in KetoCal® group.
None of the patients were excluded from the study because of the lack of ketone production. None of the patients had biochemical disorders causing the ketogenic diet to be discontinued. The random urine Ca/Cr ration was more than 0.2 in 13 patients, treated with polycitrate-potassium. 
Discussion
CKD as a potential epilepsy treatment is a high-fat, low carbohydrate diet and is strongly considered in children who failed two or three antiepileptic drugs, regardless of the age (13) (14) (15) . In addition, it is the diet of choice for the treatment of diseases such as pyruvate dehydrogenase deficiency and glucose transporter protein 1 (GLUT-1) deficiency syndrome (15) (16) (17) (18) . However, CKD as a high-fat diet has not good tolerability in some patients, and many families refuse to use the diet for the long term especially in children younger than 2 yr old.
Many prospective studies that studied the effect of CKD in the treatment of epilepsy in long term have been performed in patients older than 2 yr old (19) .
In the present study, the efficacy and tolerability of CKD only and formula-based CKD with They indicated that 28.9 % of children had a greaterthan-50%-reduction of seizures and 23.7% were seizure-free during a 12-months follow-up period.
In a research study, one-third of the patients on the ketogenic diet showed more than 90% reduction in seizure. However, completely seizure-free subjects were rare (22) . In another study, KetoCal® was used for children between 12 months and 5 yr old with refractory epilepsy who were reluctant to eat homemade food (8) . During a 4-month follow-up the median seizure frequency per week was reduced in 68.2% of patients, 40.9% showed a 50%-90% reduction in seizure frequency per week, and 27.3% showed more than 90% reduction in seizure frequency per week. Myoclonic seizure was a good prognostic factor as the patients with myoclonic seizure reacted favorably to the diet in comparison to other patients. The response rate to diet in the patients with infantile spasms, myoclonic, atonic, and tonic-clonic generalized seizures was better in comparison to complex partial seizures (23) .
In conclusion, a ketogenic diet using a powder formula (KetoCal®) is effective, safe, and tolerable in infants and children with refractory seizures.
Response rate to ketogenic diet is age-related.
The KetoCal® diet can be an appropriate choice especially for those younger than 2 yr old and patients who are reluctant to eat homemade food.
